Results 151 to 160 of about 35,230 (208)

The Physical Spectrum of a Driven Jaynes-Cummings Model. [PDF]

Entropy (Basel)
Medina-Dozal L, Urzúa AR, Ramos-Prieto I, Román-Ancheyta R, Soto-Eguibar F, Moya-Cessa HM, Récamier J.   +6 more
europepmc   +1 more source

Precision spectroscopy on ⁹Be overcomes limitations from nuclear structure. [PDF]

Nature
Dickopf S, Sikora B, Kaiser A, Müller M, Ulmer S, Yerokhin VA, Harman Z, Keitel CH, Mooser A, Blaum K.   +9 more
europepmc   +1 more source

Optimizing blood-brain barrier permeability in KRAS inhibitors: A structure-constrained molecular generation approach. [PDF]

J Pharm Anal
Sheng X, Gui Y, Yu J, Wang Y, Li Z, Zhang X, Xing Y, Wang Y, Li Z, Zheng M, Yang L, Li X.   +11 more
europepmc   +1 more source

Comparative analysis of mental and physical fatigue on motor coordination, visual search patterns, perceived effort, and performance outcomes in closed-loop aiming task. [PDF]

PLoS One
Khalaji M, Dehkordi PS, Mousavian F, Alboghebeish S.   +3 more
europepmc   +1 more source

Discovery of Potential GPRC5D Inhibitors through Virtual Screening and Molecular Dynamics Simulations. [PDF]

ChemistryOpen
Chen X, Yang X, Chen R, Xu L, Dong X, Cai Z.   +5 more
europepmc   +1 more source

Light's hidden power: Vacuum fluctuations reshape superconductivity from within. [PDF]

Proc Natl Acad Sci U S A
Nova TF, Caviglia AD.
europepmc   +1 more source

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance). [PDF]

ESMO Open
Dercle L, Geyer S, Nixon AB, Innocenti F, Shi Q, Jacobson SB, Luk L, Liu A, Yang H, Wen Y, Zhao B, Eche T, Mokrane FZ, Yang M, Meyerhardt J, O'Reilly EM, Venook AP, El-Khoueiry AB, Schwartz LH, Abou-Alfa GK.   +19 more
europepmc   +1 more source

Token-Mol 1.0: tokenized drug design with large language models. [PDF]

Nat Commun
Wang J, Qin R, Wang M, Fang M, Zhang Y, Zhu Y, Su Q, Gou Q, Shen C, Zhang O, Wu Z, Jiang D, Zhang X, Zhao H, Ge J, Wu Z, Kang Y, Hsieh CY, Hou T.   +18 more
europepmc   +1 more source

Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer. [PDF]

Clin Cancer Res
Guercio BJ, Pietzak EJ, Ravichandran V, Chen JF, Shah RH, Peters V, Regazzi AM, Niglio SA, Aggen DH, Funt SA, Donahue TF, Goh AC, Cha EK, Wong P, Richards AL, Cobbs CC, Donat SM, Dalbagni G, Bochner BH, Iyer G, Donoghue MTA, Ostrovnaya I, Al-Ahmadie HA, Rosenberg JE, Teo MY.   +24 more
europepmc   +1 more source